Regulation
3 articles

Explainers
What are the ethical considerations of gene editing technologies?
Two new studies are using base editing on human embryos, a practice legal in the UK and US.
Marcus Cole·August 14, 2026

Cosmos & Space
Drug companies ask FDA commissioner to pause new voucher program
Just months after its announcement, the FDA's Commissioner’s National Priority Voucher Program (CNPV), designed to slash drug approval times to as little as one month, is already facing calls from maj
Marcus Cole·June 5, 2026

Life & Biology
AI Leaders Urge Stricter Synthetic Biology Regulation
Leaders from OpenAI, Microsoft, and Google DeepMind have publicly urged governments to enact stricter regulations for synthetic biology.
David Grossman·June 5, 2026
